Meldonium-MIC

Meldonium-MIC (also called Meldonium or Mildronate) is an anti-ischemic medication indicated in the treatment of angina and myocardal infarction. Studies suggest that when used in combination therapy with lisinopril it can help people who have suffered chronic heart failure. Meldonium received wide-spread coverage recently due to its use by tennis player Maria Sharapova. Meldonium is now a WADA-banned substance due to its performance enhancing abilities. Meldonium is a vasoldilator and CNS stimulant that can also be used for a nootropic benefit.

Meldonium is offered in two strengths - 250mg and 500mg. When using Meldonium as a treatment for heart conditions, follow your doctor`s advice.

A common dosage for sportsmen or sportswomen looking to improve oxygen delivery, increase stamina and enrgey levels and enhance recovery is 500mg-1000mg taken twice daily, usually taken before training.

If using as a nootropic, take 500mg in the morning. If well tolerated this may be increased to a twice daily dosage. Do not take within 8 hours of going to bed or it may stop you sleeping.

Side effects that have been reported when taking Meldonium include increased blood pressure, tachycardia (higher than usual heart rate) and indigestion. If you notice any adverse reactions while taking Meldonium, contact your doctor.

Meldonium has been a banned substance by the World Anti-Doping Agency (WADA) since January 1st, 2016.

Meldonium should not be taken by pregnant or breastfeeding women.

Tell your doctor if you have any kidney or liver problems before taking Meldonium.

Meldonium can increase the antianginal effect some hypotensive drugs.